News

Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
A new study explores how healthcare providers can effectively implement Apretude for HIV pre-exposure prophylaxis (PrEP) ...
Proposed Medicaid cuts could threaten lifesaving HIV treatment access, warns Avenue 360. HOUSTON — With President Trump's " ...
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
Aurobindo Pharma to manufacture and supply long-acting injectable HIV treatment in 133 countries, offering alternative to ...
We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...
Aurobindo Pharma will manufacture and supply these injectable HIV treatment across 133 countries, including several low and ...
Aurobindo Pharma will manufacture & supply long-acting injectable HIV treatment cabotegravir across 133 countries, including ...
Both Mashatile and Motsoaledi have repeatedly lamented, correctly, the severe reliance of our health system on external donors, but have not acknowledged that they have been fully responsible for the ...
ViiV's Cabenuva is administered every two months and was offered to HIV patients who achieved viral suppression from daily treatments.